SCHEMBL220390

SCHEMBL220390

C1N=C2N=NN=C2S1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2346494 0.57
SCHEMBL3499295 0.54
SCHEMBL8688 0.32
SCHEMBL1627953 0.32
SCHEMBL7191653 0.27
SCHEMBL4601547 0.26
SCHEMBL8671944 0.26
Ammonia Solution, Strong SCHEMBL22987286 0.22
SCHEMBL10396329 0.22
Methane SCHEMBL23044967 0.22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119451573-A Agricultural combination UPL有限公司 2025-02-14 CN claimed
CN-118834343-A Molecular woven polymer aerogel material and preparation method thereof 上海交通大学 2024-10-25 CN claimed
CN-118575324-A Solid electrolyte for all-solid battery 阿科玛法国公司 2024-08-30 CN claimed
WO-2023202687-A1 PYRAZINONE DERIVATIVE AND USE THEREOF IN MEDICINE 四川海思科制药有限公司 2023-10-26 WO claimed
CN-109912626-B Thiazolotriazole superoxide dismutase agonist and preparation method and application thereof 浙江瑀美生物科技有限公司 2021-07-23 CN claimed
CN-111233850-A Naphthol derivative containing benzothiazole amino and heteroaryl, preparation method and application thereof 南开大学 2020-06-05 CN claimed
EP-2336315-B1 Enzymatic encoding methods for efficient synthesis of large libraries NUEVOLUTION AS (DK) 2017-07-19 EP claimed
US-9572794-B2 Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists VANDERBILT UNIVERSITY (US) 2017-02-21 US claimed
US-20160083363-A1 Substituted Indoles as Selective Protease Activated Receptor 4 (PAR-4) Antagonists NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-03-24 US claimed
EP-1319011-B1 TRIAZOLO-EPOTHILONES HELMHOLTZ INFEKTIONSFORSCHUNG (DE) 2012-12-05 EP claimed
US-20040014982-A1 Triazolo-epothilones HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH [HELMHOLTZ CENTER OF INFECTION RESEARCH GMBH] (DE) 2004-01-22 US claimed
JP-2002517423-A 2002-06-18 JP claimed
US-6395724-B1 COMPLEXES; ANTIINFLAMMATORY AGENTS; ANALGESICS; ANTIPYRETICS ADVANCED MEDICINE, INC. 2002-05-28 US claimed
EP-0843681-B1 HETEROCYCLE-FUSED THIAZOLE DERIVATIVES YUNGJIN PHARMACEUTICAL CO LTD (KR) 2002-03-06 EP claimed
WO-1999063939-A9 MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2 ADVANCED MEDICINE INC (US) 2001-04-12 WO claimed
EP-1085845-A2 MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2 Advanced Medicine, Inc. (US) 2001-03-28 EP claimed
US-6043373-A ANTIULCER AGENT YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 2000-03-28 US claimed
WO-1999063939-A2 MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2 ADVANCED MEDICINE, INC. (US) 1999-12-16 WO claimed
EP-0843681-A1 HETEROCYCLE-FUSED THIAZOLE DERIVATIVES YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 1998-05-27 EP claimed
WO-1997003076-A1 HETEROCYCLE-FUSED THIAZOLE DERIVATIVES YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 1997-01-30 WO claimed